Lanean...

Analysis of clinical characteristics of breast cancer patients with the Japanese founder mutation BRCA1 L63X

Background: BRCA1 and BRCA2 are high-penetrance inherited genes; different founder mutations have been reported in various areas and races. By using trial registration data from the Japanese hereditary breast and ovarian cancer syndrome (HBOC) consortium, we aimed to explore the clinicopathological...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Yoshida, Reiko, Watanabe, Chie, Yokoyama, Shiro, Inuzuka, Mayuko, Yotsumoto, Junko, Arai, Masami, Nakamura, Seigo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2019
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6524931/
https://ncbi.nlm.nih.gov/pubmed/31143373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26852
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!